361 related articles for article (PubMed ID: 22748808)
1. Phage as a modulator of immune responses: practical implications for phage therapy.
Górski A; Międzybrodzki R; Borysowski J; Dąbrowska K; Wierzbicki P; Ohams M; Korczak-Kowalska G; Olszowska-Zaremba N; Łusiak-Szelachowska M; Kłak M; Jończyk E; Kaniuga E; Gołaś A; Purchla S; Weber-Dąbrowska B; Letkiewicz S; Fortuna W; Szufnarowski K; Pawełczyk Z; Rogóż P; Kłosowska D
Adv Virus Res; 2012; 83():41-71. PubMed ID: 22748808
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of phage therapy.
Międzybrodzki R; Borysowski J; Weber-Dąbrowska B; Fortuna W; Letkiewicz S; Szufnarowski K; Pawełczyk Z; Rogóż P; Kłak M; Wojtasik E; Górski A
Adv Virus Res; 2012; 83():73-121. PubMed ID: 22748809
[TBL] [Abstract][Full Text] [Related]
3. Phages. Preface.
Łobocka M; Szybalski WT
Adv Virus Res; 2012; 83():xvii-xviii. PubMed ID: 22748816
[No Abstract] [Full Text] [Related]
4. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
Chanishvili N
Adv Virus Res; 2012; 83():3-40. PubMed ID: 22748807
[TBL] [Abstract][Full Text] [Related]
5. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
6. Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System.
Van Belleghem JD; Dąbrowska K; Vaneechoutte M; Barr JJ; Bollyky PL
Viruses; 2018 Dec; 11(1):. PubMed ID: 30585199
[TBL] [Abstract][Full Text] [Related]
7. Genomics of staphylococcal Twort-like phages--potential therapeutics of the post-antibiotic era.
Łobocka M; Hejnowicz MS; Dąbrowski K; Gozdek A; Kosakowski J; Witkowska M; Ulatowska MI; Weber-Dąbrowska B; Kwiatek M; Parasion S; Gawor J; Kosowska H; Głowacka A
Adv Virus Res; 2012; 83():143-216. PubMed ID: 22748811
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the Immune Response to Phage Therapy.
Krut O; Bekeredjian-Ding I
J Immunol; 2018 May; 200(9):3037-3044. PubMed ID: 29685950
[TBL] [Abstract][Full Text] [Related]
10. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
Kutateladze M; Adamia R
Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
[TBL] [Abstract][Full Text] [Related]
11. Phage cocktails and the future of phage therapy.
Chan BK; Abedon ST; Loc-Carrillo C
Future Microbiol; 2013 Jun; 8(6):769-83. PubMed ID: 23701332
[TBL] [Abstract][Full Text] [Related]
12. Immunogenic effect of bacteriophage in patients subjected to phage therapy.
Kucharewicz-Krukowska A; Slopek S
Arch Immunol Ther Exp (Warsz); 1987; 35(5):553-61. PubMed ID: 3455646
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophages and cancer.
Budynek P; Dabrowska K; Skaradziński G; Górski A
Arch Microbiol; 2010 May; 192(5):315-20. PubMed ID: 20232198
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
Burrowes B; Harper DR; Anderson J; McConville M; Enright MC
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
[TBL] [Abstract][Full Text] [Related]
15. [What happens when the child gets bacteriophage per os?].
Pagava KI; Gachechiladze KK; Korinteli IA; Dzuliashvili MG; Alavidze ZI; Hoyle N; Metskhvarishvili GD
Georgian Med News; 2011; (196-197):101-5. PubMed ID: 21873760
[TBL] [Abstract][Full Text] [Related]
16. Optimal bacteriophage mutation rates for phage therapy.
Kysela DT; Turner PE
J Theor Biol; 2007 Dec; 249(3):411-21. PubMed ID: 17904162
[TBL] [Abstract][Full Text] [Related]
17. The next generation of bacteriophage therapy.
Lu TK; Koeris MS
Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281
[TBL] [Abstract][Full Text] [Related]
18. Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.
Jończyk-Matysiak E; Weber-Dąbrowska B; Owczarek B; Międzybrodzki R; Łusiak-Szelachowska M; Łodej N; Górski A
Viruses; 2017 Jun; 9(6):. PubMed ID: 28613272
[TBL] [Abstract][Full Text] [Related]
19. The potential role of endogenous bacteriophages in controlling invading pathogens.
Górski A; Weber-Dabrowska B
Cell Mol Life Sci; 2005 Mar; 62(5):511-9. PubMed ID: 15747058
[TBL] [Abstract][Full Text] [Related]
20. [Some immunological changes in children with bacterial infections treated with bacteriophages].
Pagava KI; Metskhvarishvili GD; Gachechiladze KK; Korinteli IA; Khoĭle N; Dzuliashvili MG
Georgian Med News; 2012 Nov; (212):64-9. PubMed ID: 23221141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
